Cargando…

The Role of Dual-Energy CT for the Assessment of Liver Metastasis Response to Treatment: Above the RECIST 1.1 Criteria

Imaging assessment of liver lesions is fundamental to predict therapeutic response and improve patient survival rates. Dual-Energy Computed Tomography (DECT) is an increasingly used technique in the oncologic field with many emerging applications. The assessment of iodine concentration within a live...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reginelli, Alfonso, Del Canto, Mariateresa, Clemente, Alfredo, Gragnano, Eduardo, Cioce, Fabrizio, Urraro, Fabrizio, Martinelli, Erika, Cappabianca, Salvatore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917684/ https://www.ncbi.nlm.nih.gov/pubmed/36769527 http://dx.doi.org/10.3390/jcm12030879

Ejemplares similares

An overview of the irreversible electroporation for the treatment of liver metastases: When to use it
por: Belfiore, Maria Paola, et al.
Publicado: (2022)

Artificial intelligence to codify lung CT in Covid-19 patients
por: Belfiore, Maria Paola, et al.
Publicado: (2020)

Chemotherapy-induced bowel ischemia: diagnostic imaging overview
por: Reginelli, Alfonso, et al.
Publicado: (2021)

Langerhans Cell Histiocytosis with Uncommon Liver Involvement: A Case Report
por: Reginelli, Alfonso, et al.
Publicado: (2020)

Response Evaluation and Survival Prediction Following PD‐1 Inhibitor in Patients With Advanced Hepatocellular Carcinoma: Comparison of the RECIST 1.1, iRECIST, and mRECIST Criteria
por: Zhou, Meng, et al.
Publicado: (2021)

Imaging of pediatric foot disorders
por: Reginelli, Alfonso, et al.
Publicado: (2018)

Colonic Lipoma Causing Bowel Intussusception: An Up-to-Date Systematic Review
por: Menegon Tasselli, Francesco, et al.
Publicado: (2021)

Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602
por: Sato, Yozo, et al.
Publicado: (2013)

Patterns of response in metastatic NSCLC during PD‐1 or PD‐L1 inhibitor therapy: Comparison of the RECIST 1.1 and iRECIST criteria
por: Liang, Hongge, et al.
Publicado: (2020)

RECIST criteria: our experience in daily practice
por: De Luca, S, et al.
Publicado: (2015)

Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST
por: Costelloe, Colleen M., et al.
Publicado: (2010)

Endorectal Ultrasound and Magnetic Resonance Imaging for Rectal Cancer Staging: A Modern Multimodality Approach
por: Reginelli, Alfonso, et al.
Publicado: (2021)

Extranodal lymphomas: a pictorial review for CT and MRI classification
por: Reginelli, Alfonso, et al.
Publicado: (2020)

COVID-19 pneumonia: computer-aided quantification of healthy lung parenchyma, emphysema, ground glass and consolidation on chest computed tomography (CT)
por: Grassi, Roberto, et al.
Publicado: (2020)

The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization
por: Lee, Jae Seung, et al.
Publicado: (2020)

Radiomics as a New Frontier of Imaging for Cancer Prognosis: A Narrative Review
por: Reginelli, Alfonso, et al.
Publicado: (2021)

Response Criteria for Intratumoral Immunotherapy in Solid Tumors: itRECIST
por: Goldmacher, Gregory V., et al.
Publicado: (2020)

Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival
por: Manitz, Juliane, et al.
Publicado: (2022)

Comparison of RECIST 1.0 and RECIST 1.1 in Patients with Metastatic Cancer: A Pooled Analysis
por: Kim, Jung Han, et al.
Publicado: (2015)

Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?
por: Luo, Yanji, et al.
Publicado: (2017)

Learning From Mistakes: Importance of a Multidisciplinary Group, A Case Report
por: Pezzulla, Donato, et al.
Publicado: (2016)

Coronavirus disease 2019 (COVID-19) in Italy: features on chest computed tomography using a structured report system
por: Roberto, Grassi, et al.
Publicado: (2020)

Author Correction: Coronavirus disease 2019 (COVID-19) in Italy: features on chest computed tomography using a structured report system
por: Grassi, Roberto, et al.
Publicado: (2021)

Coronavirus Disease 2019 (COVID-19) in Italy: Double Reading of Chest CT Examination
por: Reginelli, Alfonso, et al.
Publicado: (2021)

Management of Non-Melanoma Skin Cancer: Radiologists Challenging and Risk Assessment
por: Russo, Gaetano Maria, et al.
Publicado: (2023)

Comparison of the RECIST 1.0 and RECIST 1.1 in Non-Small Cell Lung Cancer Treated with Cytotoxic Chemotherapy
por: Choi, Hyun Chang, et al.
Publicado: (2015)

Comparison of the RECIST 1.0 and RECIST 1.1 in patients treated with targeted agents: a pooled analysis and review
por: Kim, Jung Han
Publicado: (2016)

MRI Radiomics in Prostate Cancer: A Reliability Study
por: Urraro, Fabrizio, et al.
Publicado: (2021)

Magnetic Resonance Imaging Evaluation of Bone Metastases Treated with Radiotherapy in Palliative Intent: A Multicenter Prospective Study on Clinical and Instrumental Evaluation Assessment Concordance (MARTE Study)
por: Reginelli, Alfonso, et al.
Publicado: (2023)

RECIST rules
por: Sohaib, Aslam
Publicado: (2012)

WHO, RECIST, and immune-related response criteria: is it time to revisit pembrolizumab results?
por: Ades, Felipe, et al.
Publicado: (2015)

Comparison of the RECIST and PERCIST criteria in solid tumors: a pooled analysis and review
por: Min, Seon Jeong, et al.
Publicado: (2016)

Evolution of CT Findings and Lung Residue in Patients with COVID-19 Pneumonia: Quantitative Analysis of the Disease with a Computer Automatic Tool
por: Grassi, Roberto, et al.
Publicado: (2021)

Comparison of RECIST 1.1 and iRECIST in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
por: Park, Hyo Jung, et al.
Publicado: (2021)

Comparison of the morphologic criteria (RECIST) and metabolic criteria (EORTC and PERCIST) in tumor response assessments: a pooled analysis
por: Kim, Hong Deok, et al.
Publicado: (2019)

Comparison of Choi, RECIST and Somatostatin Receptor PET/CT Based Criteria for the Evaluation of Response and Response Prediction to PRRT
por: Zwirtz, Kevin, et al.
Publicado: (2022)

Peritoneal Carcinosis: What the Radiologist Needs to Know
por: Reginelli, Alfonso, et al.
Publicado: (2023)

Clinical and laboratory data, radiological structured report findings and quantitative evaluation of lung involvement on baseline chest CT in COVID-19 patients to predict prognosis
por: Salvatore, Cappabianca, et al.
Publicado: (2020)

Comparative prognostic implication of treatment response assessments in mCRPC: PERCIST 1.0, RECIST 1.1, and PSA response criteria
por: Velez, Erik M., et al.
Publicado: (2020)

Correction to: Clinical and laboratory data, radiological structured report findings and quantitative evaluation of lung involvement on baseline chest CT in COVID-19 patients to predict prognosis
por: Cappabianca, Salvatore, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_js847jiaevbk1nalkfabcmlh9j